These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2143150)

  • 1. Effect of 6-aminonicotinamide on pentose cycle activity in isolated hepatocytes.
    Carmona A; Freedland RA
    Int J Biochem; 1990; 22(6):595-9. PubMed ID: 2143150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of 6-aminonicotinamide (6AN) on Leishmania promastigotes evaluated by metabolomics: Beyond the pentose phosphate pathway.
    Almugadam SH; Trentini A; Maritati M; Contini C; Rugna G; Bellini T; Manfrinato MC; Dallocchio F; Hanau S
    Chem Biol Interact; 2018 Oct; 294():167-177. PubMed ID: 30170107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentose cycle flux and fatty acid synthesis in bovine adipose tissue slices incubated with 6-aminonicotinamide.
    Smith SB; Prior RL
    Proc Soc Exp Biol Med; 1984 Jan; 175(1):98-105. PubMed ID: 6229798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism via the pentose phosphate pathway in rat pheochromocytoma PC12 cells: effects of nerve growth factor and 6-aminonicotinamide.
    Davis LH; Kauffman FC
    Neurochem Res; 1987 Jun; 12(6):521-7. PubMed ID: 2955240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 6-aminonicotinamide on renin release in isolated rat kidney: possible role for the pentose pathway.
    Rostand SG; Work J
    Am J Physiol; 1985 Aug; 249(2 Pt 2):F213-9. PubMed ID: 3161339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 6-aminonicotinamide on the pentose phosphate pathway: 31P NMR and tumor growth delay studies.
    Koutcher JA; Alfieri AA; Matei C; Meyer KL; Street JC; Martin DS
    Magn Reson Med; 1996 Dec; 36(6):887-92. PubMed ID: 8946354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of metabolic and radiobiological effects of 6-aminonicotinamide in RIF-1 tumor cells in vitro.
    Street JC; Alfieri AA; Koutcher JA
    Cancer Res; 1997 Sep; 57(18):3956-62. PubMed ID: 9307279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. tert.-Butyl hydroperoxide metabolism and stimulation of the pentose phosphate pathway in isolated rat hepatocytes.
    Rush GF; Alberts D
    Toxicol Appl Pharmacol; 1986 Sep; 85(3):324-31. PubMed ID: 2945286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interrelationship and control of glucose metabolism and lipogenesis in isolated fat-cells. Control of pentose phosphate-cycle activity by cellular requirement for reduced nicotinamide adenine dinucleotide phosphate.
    Kather H; Rivera M; Brand K
    Biochem J; 1972 Aug; 128(5):1097-102. PubMed ID: 4404963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of pentose cycle of A549 cells by 6-aminonicotinamide: consequences for aerobic and hypoxic radiation response and for radiosensitizer action.
    Varnes ME
    NCI Monogr; 1988; (6):199-203. PubMed ID: 2965307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo detection by 31P NMR of pentose phosphate pathway block secondary to biochemical modulation.
    Mahmood U; Street JC; Matei C; Ballon D; Martin DS; Koutcher JA
    NMR Biomed; 1996 May; 9(3):114-20. PubMed ID: 8892397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spastic paresis after 6-aminonicotinamide: metabolic disorders in the spinal cord and electromyographically recorded changes in the hind limbs of rats.
    Herken H; Meyer-Estorf G; Halbhübner K; Loos D
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Jun; 293(3):245-55. PubMed ID: 134291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 6-Aminonicotinamide inhibition of the pentose phosphate pathway in rat neocortex.
    Tyson RL; Perron J; Sutherland GR
    Neuroreport; 2000 Jun; 11(9):1845-8. PubMed ID: 10884030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative pathways of glucose utilization in brain; changes in the pattern of glucose utilization in brain resulting from treatment of rats with 6-aminonicotinamide.
    Hothersall JS; Zubairu S; McLean P; Greenbaum AL
    J Neurochem; 1981 Dec; 37(6):1484-96. PubMed ID: 6460850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic consequences of drug-induced inhibition of the pentose phosphate pathway in neuroblastoma and glioma cells.
    Kolbe H; Keller K; Lange K; Herken H
    Biochem Biophys Res Commun; 1976 Nov; 73(2):378-82. PubMed ID: 136966
    [No Abstract]   [Full Text] [Related]  

  • 16. [Will inhibition of the hexose monophosphate shunt increase resistance to oxygen deficiency?].
    Trojan S
    Sb Lek; 1987; 89(11-12):330-4. PubMed ID: 2965406
    [No Abstract]   [Full Text] [Related]  

  • 17. Decreased glycolytic flux rate in the isolated perfused rat brain after pretreatment with 6-aminonicotinamide.
    Krieglstein J; Stock R
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 290(2-3):323-7. PubMed ID: 127127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of biopterin synthesis and DOPA production in PC-12 pheochromocytoma cells induced by 6-aminonicotinamide.
    Jung W; Herken H
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Apr; 339(4):424-32. PubMed ID: 2525671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of glucose into glutamate via the hexose monophosphate shunt and its inhibition by 6-aminonicotinamide in rat brain in vivo.
    Gaitonde MK; Jones J; Evans G
    Proc R Soc Lond B Biol Sci; 1987 Jun; 231(1262):71-90. PubMed ID: 2888118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of 6-aminonicotinamide on the renal transport of para-aminohippurate in the rat.
    Sudo J; Ishihara A; Tanabe T
    Jpn J Pharmacol; 1984 Dec; 36(4):491-8. PubMed ID: 6241269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.